Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
|Videos|July 9, 2021
Understanding Treatment Options in Melanoma
Author(s)Kristie L. Kahl
On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Talzenna Plus Xtandi in Hormone-Sensitive Prostate Cancer
2
What New KRAS Drug Data From ESMO 2026 Mean for Patients
3
Working During Cancer Treatment: Your FMLA and ADA Rights
4
Imdelltra Plus Imfinzi Extends Survival in Small Cell Lung Cancer
5